Advocacy in Action: Public Policy Advocacy For Cancer

Vital Options International presents Advocacy in Action, bringing together the influential leaders of the cancer advocacy community to address Public Policy Advocacy For Cancer.

Public policies may encourage or prohibit further advancements or access to the latest care and treatments. Although cancer survivors are more likely to return to their jobs and families, they are forever changed by their experiences. Legislators may have a different view the role of public policies after they consider the issues of cancer survivors and their families.

There are many legislative and regulatory issues that surround Public Policy Advocacy and impact oncology care and that influence clinical advancements and access to treatment.  Some of the issues in cancer public policy include:

  • Drug Shortages
  • Advanced Cancer Care Planning
  • NIH/NCI/FDA Appropriations
  • Access to Care
  • Value in Cancer Care
  • Drug Safety
  • Reimbursement
  • Medicare

Joining Vital Options CEO, Selma Schimmel, as co-moderators for Public Policy Advocacy in Cancer Care will be Nancy Davenport-Ennis, Patient Advocate Foundation; Linda House, Cancer Support Community; Ted Okon, Community Oncology Alliance; Charles Penley, MD, ASCO Government Relations Committee; and Scott Williams, Men’s Health Network.

Videos In This Series Include:

Advocacy in Action: Public Policy Issues For Cancer Advocates

Advocacy In Action: Creating More Support for Cancer Public Policy Initiatives

Advocacy in Action: Helping Patients Find Their Advocacy Voices

Advocacy in Action: How Do We Help Patient Advocates Find Their Power?

American Society of Clinical Oncology (ASCO) Public Policy Initiatives

Cancer Support Community Public Policy Initiatives

Community Oncology Alliance (COA) Public Policy Initiatives

Men’s Health Network Public Policy Initiatives

National Patient Advocate Foundation (NPAF) Public Policy Initiatives

Advocacy in Action at the American Society of Clinical Oncology (ASCO) Annual Meeting 2012 was made possible, in part, by:

Comments